Form 4 for ONC BeOne Medicines Ltd.
Accepted 2025-06-12 00:00:00 ET · period of report 2025-06-10 · accession 0001651308-25-000110 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-06-12 | 2025-06-11 | ONC | Ball Titus B. | Principal Accounting Off | S - Sale | $258.36 | -134 | 0 | -100% | -$34.6K | |
| 2025-06-12 | 2025-06-10 | ONC | Ball Titus B. | Principal Accounting Off | A - Grant | $0.00 | +29.6K | 74.0K | +67% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | American Depositary Shares | 2025-06-11 | S | D | 134 | $258.36 | 0 | D | — | — | (F2) Each American Depositary Share represents 13 Ordinary Shares. |
| 2 | Common | Ordinary Shares | 2025-06-10 | A | A | 29,601 | $0.00 | 73,983 | D | — | — | (F1) Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 10, 2025, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events. |